Table 5.
Source | Model | Training Set | Validation Set | |||
---|---|---|---|---|---|---|
N | R2 | Q2 | n | R2PRED | ||
This study | PLS | 150 | 0.80 | 0.77 | 65 | 0.81 |
Ambure et al. 2016 [79] | PLS | 52 | 0.83 | 0.76 | 22 | 0.81 |
Ambure et al. 2016 [79] | MLR | 51 | 0.83 | 0.76 | 22 | 0.80 |
Hossain et al. 2013 [80] | CoMFA | 71 | 1.00 | 0.77 | 35 | 0.77 |
Hossain et al. 2013 [80] | CoMSIA | 71 | 1.00 | 0.73 | 35 | 0.71 |
Hossain et al. 2013 [80] | PLS | 71 | 0.94 | 0.79 | 35 | 0.71 |
Roy et al. 2018 [77] | MLR | 51 | 0.76–0.83 | 0.71–0.76 | 23 | 0.75–0.91 |
PLS: Partial least squares; MLR: Multiple linear regression; CoMFA: Comparative molecular field analysis; CoMSIA: Comparative similarity indices analysis; LHM: Linear heuristic method; N: number of compounds.